Highlights
Apotheca Biosciences’ (CBDC) Distribution of ProMED’s Pharma Grade CBD Produ
Saint Petersburg, FL, May 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: CBDC), a
AbbVie ends Phase III brain tumour study due to failed primary goal
Enrolment in all ongoing Depatux-M studies has been halted.
ECH makes moves toward facilitating medical cannabis importation in UK, EU
Astral Health will act as a gateway to the European cannabis market.
Trends in Medical Device Recalls
A recent project conducted by Northeastern graduate students looked at device recalls over the past five years and so
Melons Are Powerhouses in Taste, Nutrition
TUESDAY, May 21, 2019 -- If you're looking for a tasty way to hydrate in warm weather, a juicy melon is the ticket.
Health Highlights: May 21, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:nlBill Would Ra
Categories refined for the 2019 Medical & Scientific Excellence Awards
The categories in the 2019 PharmaTimes Medical & Scientific Excellence Awards have been refined to greater reflect t
Health Tip: Signs of an Unhealthy Relationship
-- Relationships are a necessary part of healthy living. Though no relationship is perfect, an unhealthy relationship ca
Health Tip: Escaping Rip Currents
-- Most beach rescues performed by lifeguards are caused by rip currents -- strong currents that can pull swimmers under
Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study,
INDIANAPOLIS, May 21, 2019 /PRNewswire/ -- In an oral presentation from the Digestive Disease Week medical conference in
Dendreon extends lease on cell therapy plant to 2030
Dendreon Pharmaceuticals has extended the lease on its immunotherapy manufacturing facility in California through to 203
UPDATE: Hepatitis cases linked to turmeric supplements rumble on as incidences rise to ten
Italyâs National Institute of Health reports a further six new hepatitis incidences linked to the consumption of turm